Displaying 31 - 60 of 2461
The total percentage of children with arsenic levels above the reference value increased to 57%, with the percentage increase being even more significant in regions near disaster areas
Among the 14 selected is the work Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults, in which two researchers from Fiocruz Bahia were involved
The first generation of children affected by the microcephaly outbreak in 2015 are now around ten years old. Only a minority of these children survived their first year of life
The program has not only reduced mortality rates among hospitalized with mental disorders but could also prevent more deaths
The event will bring together professionals from the public health sector, researchers, and students from Brazil and around the world, from May 7 to 9, in Rio de Janeiro
Fiocruz Vaccine Technical Committee issued a critical statement regarding an article published by the scientific journal 'Frontiers in Medicine'
A research conducted by Fiocruz and ISGlobal shows that social protection programs, such as Bolsa Família in Brazil, can help achieve global targets for tuberculosis control
The WHO strategy highlights research and development as a central element in the prevention, preparedness, and response to epidemics and pandemics
Amazonia BR/UK event will discuss the effects of climate change on the health of the population
Fiocruz Pernambuco received the dean of the university of Guinea-Bissau for a visit that symbolized the beginning of a cooperative relationship
Researchers visited the triple border between Brazil, Colombia and Peru and the binational border between Brazil and French Guiana
Em defesa da saúde pública, instituições se manifestam a favor de lei que proíbe a pulverização aérea de agrotóxicos, sobretudo no estado do Ceará, que se encontra ameaçada frente à liberação do uso de drones
The pneumologist and researcher at the National School of Public Health Sergio Arouca (ENSP/Fiocruz) is described in the article as “the Brazil’s face of COVID-19”
Milena Soares, a researcher at Fiocruz Bahia, was elected a member of The World Academy of Sciences for the Advancement of Science in Developing Countries (TWAS) in the area of Medical and Health Sciences
Internacional
Advanced therapies are cell, gene and tissue bioengineering therapies, and are considered a new category of drugs by Anvisa. The trial was approved after analysis of the dossiers submitted
